Serena Corsetti

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva

Michele Bartoletti, Roberta Mazzeo, Marco de Scordilli et al. · International Journal of Gynecological Cancer · 2020 · 32 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure

Rossana Roncato, Elena Peruzzi, Lorenzo Gerratana et al. · Biomedicine & Pharmacotherapy · 2023 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring

Giovanni Canil, Marco Orleni, Bianca Posocco et al. · Pharmaceutics · 2023 · 18 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines

Patrizia Vici, Luigi Di Lauro, Domenico Sergi et al. · Oncology · 2008 · 15 citations

Medicine, Oncology, Pharmacology +12